pacritinib   Click here for help

GtoPdb Ligand ID: 7793

Synonyms: SB-1518 | SB1518 | Vonjo®
Approved drug PDB Ligand
pacritinib is an approved drug (FDA (2022))
Compound class: Synthetic organic
Comment: Pacritinib is an orally bioavailable and somewhat selective inhibitor of Janus kinase 2 (JAK2) and the JAK2 gain-of-function mutant JAK2V617F [3]. At clinically relevant concentrations, pacritinib does not inhibit JAK1. It also has some inhibitory activity against FMS-like tyrosine kinase 3 (FLT3).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 68.74
Molecular weight 472.25
XLogP 4.16
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES C1C=CCOCc2cc(ccc2OCCN2CCCC2)Nc2nc(c3cc(CO1)ccc3)ccn2
Isomeric SMILES C1/C=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nc(c3cc(CO1)ccc3)ccn2
InChI InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+
Classification Click here for help
Compound class Synthetic organic
Approved drug? Yes (FDA (2022))
IUPAC Name Click here for help
International Nonproprietary Names Click here for help
INN number INN
9385 pacritinib
Synonyms Click here for help
SB-1518 | SB1518 | Vonjo®
Database Links Click here for help
CAS Registry No. 937272-79-2
ChEMBL Ligand CHEMBL2035187
GtoPdb PubChem SID 223366124
PubChem CID 46216796
RCSB PDB Ligand 6T3
Search Google for chemical match using the InChIKey HWXVIOGONBBTBY-ONEGZZNKSA-N
Search Google for chemicals with the same backbone HWXVIOGONBBTBY
Search PubMed clinical trials pacritinib
Search PubMed titles pacritinib
Search PubMed titles/abstracts pacritinib
UniChem Compound Search for chemical match using the InChIKey HWXVIOGONBBTBY-ONEGZZNKSA-N
UniChem Connectivity Search for chemical match using the InChIKey HWXVIOGONBBTBY-ONEGZZNKSA-N
Wikipedia Pacritinib